Yasuko Kato Selected Research

Yasuko Kato Research Topics

Disease

3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2013 - 01/2012
3	Anaphylaxis (Anaphylactic Shock) 01/2011 - 12/2005
3	Exercise-Induced Allergies 01/2011 - 01/2006
2	Thrombosis (Thrombus) 07/2013 - 07/2003
2	Pathologic Constriction (Stenosis) 01/2011 - 10/2009
1	Bone Resorption 06/2022
1	Osteoporosis 06/2022
1	Myocardial Infarction 07/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Chromosome Inversion (Chromosomal Inversion) 01/2018
1	Ventricular Tachycardia 01/2017
1	Coronary Disease (Coronary Heart Disease) 01/2017
1	Hyperemia 01/2017
1	Fanconi Anemia (Fanconi's Anemia) 10/2016
1	Complementation Group D1 Fanconi Anemia 10/2016
1	Ulcer 07/2013
1	Stomach Ulcer (Gastric Ulcer) 07/2013
1	Hyperaldosteronism (Conn Syndrome) 12/2012
1	Heart Failure 01/2012
1	Virus Diseases (Viral Diseases) 11/2010
1	Hyperplasia 10/2009
1	Infections 03/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2008
1	Arthritis (Polyarthritis) 12/2005
1	Experimental Arthritis 12/2005
1	Contact Dermatitis (Eczema, Contact) 12/2005
1	Urticaria (Hives) 12/2005
1	Hypersensitivity (Allergy) 12/2005
1	Carotid Artery Thrombosis 07/2003

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2006
3	GliadinIBA 01/2011 - 01/2006
2	PapaverineIBA 01/2017 - 01/2017
2	Immunoglobulin E (IgE)IBA 01/2011 - 06/2008
2	AllergensIBA 01/2011 - 01/2011
1	tartaric acid (tartrate)FDA Link 06/2022
1	deoxypyridinolineIBA 06/2022
1	AcidsIBA 06/2022
1	Prednisolone (Predate)FDA LinkGeneric 06/2022
1	Radioisotopes (Radionuclides)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Contrast MediaIBA 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	Discoidin Domain ReceptorsIBA 10/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2013
1	3- methoxy- 1,5- bis(4- methoxyphenyl)- 1H- 1,2,4- triazoleIBA 07/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2013
1	LipidsIBA 01/2013
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2013
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2013
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2013
1	aliskiren FDA Link 01/2013
1	LDL CholesterolIBA 01/2013
1	PotassiumIBA 12/2012
1	Eicosapentaenoic AcidIBA 01/2012
1	Sirolimus (Rapamycin)FDA Link 01/2011
1	InterferonsIBA 11/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2010
1	resiquimodIBA 11/2010
1	LigandsIBA 11/2010
1	Proteoglycans (Proteoglycan)IBA 10/2009
1	LipopolysaccharidesIBA 06/2008
1	Immunoglobulin G (IgG)IBA 06/2008
1	Histamine (Histamine Dihydrochloride)FDA Link 06/2008
1	Toll-Like Receptor 4IBA 06/2008
1	Poly I-CIBA 03/2008
1	omega-Chloroacetophenone (Mace)IBA 01/2008
1	gluteninIBA 01/2006
1	Messenger RNA (mRNA)IBA 12/2005
1	CytokinesIBA 12/2005
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2005
1	Glutamic Acid (Glutamate)FDA Link 12/2005
1	Excitatory Amino AcidsIBA 12/2005
1	Collagen Type II (Type II Collagen)IBA 12/2005
1	ChitosanIBA 12/2005
1	ChitinIBA 12/2005
1	FR 171113IBA 07/2003
1	PAR-1 ReceptorIBA 07/2003

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2013
2	Stents 01/2011 - 10/2009
1	Oral Administration 06/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 07/2019
1	Nuclear Power Plants 01/2018
1	Intra-Aortic Balloon Pumping 01/2012
1	Percutaneous Coronary Intervention 01/2011
1	Aftercare (After-Treatment) 11/2010